Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glaucoma | 4 | 2018 | 87 | 1.090 |
Why?
|
| Sickness Impact Profile | 1 | 2018 | 36 | 0.580 |
Why?
|
| Trabeculectomy | 2 | 2016 | 17 | 0.550 |
Why?
|
| Surgically-Created Structures | 1 | 2013 | 5 | 0.420 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2013 | 51 | 0.400 |
Why?
|
| Visual Fields | 2 | 2010 | 133 | 0.400 |
Why?
|
| Glaucoma, Open-Angle | 2 | 2009 | 38 | 0.390 |
Why?
|
| Visual Field Tests | 1 | 2010 | 48 | 0.350 |
Why?
|
| Blindness | 1 | 2009 | 72 | 0.310 |
Why?
|
| Quality of Life | 1 | 2018 | 1915 | 0.300 |
Why?
|
| Ophthalmology | 1 | 2010 | 198 | 0.290 |
Why?
|
| Intracranial Thrombosis | 1 | 2006 | 12 | 0.270 |
Why?
|
| Cerebral Veins | 1 | 2006 | 16 | 0.270 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2006 | 48 | 0.260 |
Why?
|
| Pseudotumor Cerebri | 1 | 2006 | 58 | 0.250 |
Why?
|
| Cavernous Sinus | 1 | 2004 | 22 | 0.230 |
Why?
|
| Orbital Neoplasms | 1 | 2004 | 65 | 0.220 |
Why?
|
| Primary Health Care | 1 | 2009 | 771 | 0.210 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 350 | 0.180 |
Why?
|
| Ocular Hypotension | 1 | 1999 | 4 | 0.160 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 23 | 0.160 |
Why?
|
| Silicone Oils | 1 | 1999 | 11 | 0.160 |
Why?
|
| Organophosphonates | 1 | 1999 | 20 | 0.160 |
Why?
|
| Ciliary Body | 1 | 1999 | 31 | 0.160 |
Why?
|
| Cytosine | 1 | 1999 | 56 | 0.150 |
Why?
|
| Vitrectomy | 1 | 1999 | 108 | 0.150 |
Why?
|
| Eye Diseases | 1 | 1999 | 116 | 0.140 |
Why?
|
| Intraocular Pressure | 2 | 2016 | 144 | 0.130 |
Why?
|
| Medical Staff, Hospital | 1 | 2016 | 93 | 0.130 |
Why?
|
| Brain Neoplasms | 1 | 2004 | 1207 | 0.120 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 401 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 1644 | 0.110 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 475 | 0.110 |
Why?
|
| Antimetabolites | 1 | 2013 | 33 | 0.100 |
Why?
|
| Aged | 6 | 2016 | 19700 | 0.090 |
Why?
|
| Visual Acuity | 2 | 2013 | 817 | 0.080 |
Why?
|
| Observer Variation | 1 | 2010 | 299 | 0.080 |
Why?
|
| Reoperation | 1 | 2013 | 832 | 0.080 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2009 | 102 | 0.080 |
Why?
|
| Humans | 12 | 2018 | 124592 | 0.070 |
Why?
|
| Clinical Competence | 2 | 2016 | 998 | 0.070 |
Why?
|
| Nerve Fibers | 1 | 2008 | 73 | 0.070 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2006 | 16 | 0.070 |
Why?
|
| Retinal Ganglion Cells | 1 | 2008 | 99 | 0.070 |
Why?
|
| Phlebography | 1 | 2006 | 50 | 0.070 |
Why?
|
| Optic Nerve Diseases | 1 | 2008 | 88 | 0.070 |
Why?
|
| Vision Disorders | 1 | 2008 | 211 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2006 | 160 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2016 | 1176 | 0.060 |
Why?
|
| Papilledema | 1 | 2006 | 78 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2009 | 542 | 0.060 |
Why?
|
| Deferoxamine | 1 | 2004 | 7 | 0.060 |
Why?
|
| Iron Chelating Agents | 1 | 2004 | 14 | 0.060 |
Why?
|
| Disease Progression | 1 | 2010 | 2047 | 0.060 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2004 | 116 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2876 | 0.050 |
Why?
|
| Male | 6 | 2016 | 61194 | 0.050 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2003 | 7 | 0.050 |
Why?
|
| Ovarian Cysts | 1 | 2003 | 21 | 0.050 |
Why?
|
| Retinal Diseases | 1 | 2004 | 171 | 0.050 |
Why?
|
| Retina | 1 | 2004 | 450 | 0.040 |
Why?
|
| Colitis, Ulcerative | 1 | 2003 | 205 | 0.040 |
Why?
|
| Cytomegalovirus Retinitis | 1 | 1999 | 16 | 0.040 |
Why?
|
| Female | 6 | 2016 | 66483 | 0.040 |
Why?
|
| Middle Aged | 4 | 2016 | 26712 | 0.040 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1999 | 136 | 0.040 |
Why?
|
| Lens, Crystalline | 1 | 1999 | 137 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2013 | 12324 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 2090 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2016 | 16312 | 0.030 |
Why?
|
| Lens Implantation, Intraocular | 1 | 1999 | 342 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 1998 | 543 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 2016 | 359 | 0.030 |
Why?
|
| Ultrasonography | 1 | 1999 | 931 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1032 | 0.030 |
Why?
|
| Risk Factors | 1 | 2006 | 10265 | 0.020 |
Why?
|
| Adult | 2 | 2016 | 29435 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 6533 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 2045 | 0.020 |
Why?
|
| Adolescent | 1 | 2006 | 19275 | 0.020 |
Why?
|
| Ophthalmoscopy | 1 | 2008 | 28 | 0.020 |
Why?
|
| Tomography | 1 | 2008 | 41 | 0.020 |
Why?
|
| Optic Disk | 1 | 2008 | 44 | 0.020 |
Why?
|
| Child | 1 | 2006 | 24367 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2004 | 138 | 0.010 |
Why?
|
| Fertility | 1 | 2003 | 257 | 0.010 |
Why?
|
| Neural Tube Defects | 1 | 2004 | 355 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 658 | 0.010 |
Why?
|
| Prevalence | 1 | 2003 | 2445 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1998 | 830 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1998 | 526 | 0.010 |
Why?
|
| Binding Sites | 1 | 1998 | 1295 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 1390 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 1998 | 573 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 2705 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 3878 | 0.010 |
Why?
|
| DNA | 1 | 1998 | 1597 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1998 | 1265 | 0.010 |
Why?
|
| Animals | 1 | 1998 | 34086 | 0.000 |
Why?
|